Mouse models for muscular dystrophies: an overview

被引:32
|
作者
van Putten, Maaike [1 ]
Lloyd, Erin M. [2 ]
de Greef, Jessica C. [1 ]
Raz, Vered [1 ]
Willmann, Raffaella [3 ]
Grounds, Miranda D. [2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands
[2] Univ Western Australia, Sch Human Sci, Perth, WA 6009, Australia
[3] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland
关键词
Disease pathology; Mouse models; Muscular dystrophy; LAMININ ALPHA-2; ANIMAL-MODELS; TARGETED DISRUPTION; MUSCLE MEMBRANE; GENE; MICE; MDX; PATHOLOGY; IDENTIFICATION; DEGENERATION;
D O I
10.1242/dmm.043562
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Muscular dystrophies (MDs) encompass a wide variety of inherited disorders that are characterized by loss of muscle tissue associated with a progressive reduction in muscle function. With a cure lacking for MDs, preclinical developments of therapeutic approaches depend on well-characterized animal models that recapitulate the specific pathology in patients. The mouse is the most widely and extensively used model for MDs, and it has played a key role in our understanding of the molecular mechanisms underlying MD pathogenesis. This has enabled the development of therapeutic strategies. Owing to advancements in genetic engineering, a wide variety of mouse models are available for the majority of MDs. Here, we summarize the characteristics of the most commonly used mouse models for a subset of highly studied MDs, collated into a table. Together with references to key publications describing these models, this brief but detailed overview would be useful for those interested in, or working with, mouse models of MD.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Cardiac involvement in the muscular dystrophies
    Silvestri, Nicholas J.
    Ismail, Haisam
    Zimetbaum, Peter
    Raynor, Elizabeth M.
    MUSCLE & NERVE, 2018, 57 (05) : 707 - 715
  • [32] Cardiac manifestations of muscular dystrophies
    Perrot, A
    Spuler, S
    Geier, C
    Dietz, R
    Osterziel, KJ
    ZEITSCHRIFT FUR KARDIOLOGIE, 2005, 94 (05): : 312 - +
  • [33] Molecular Therapies for Muscular Dystrophies
    Lin, Ava Y.
    Wang, Leo H.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (07)
  • [34] Molecular Therapies for Muscular Dystrophies
    Ava Y. Lin
    Leo H. Wang
    Current Treatment Options in Neurology, 2018, 20
  • [35] Cardiac manifestations of muscular dystrophies
    Perrot A.
    Spuler S.
    Geier C.
    Dietz R.
    Osterziel K.J.
    Zeitschrift für Kardiologie, 2005, 94 (5): : 312 - 320
  • [36] Limb girdle muscular dystrophies
    Finsterer, J
    NERVENARZT, 2004, 75 (12): : 1153 - +
  • [37] Molecular basis of muscular dystrophies
    Cohn, RD
    Campbell, KP
    MUSCLE & NERVE, 2000, 23 (10) : 1456 - 1471
  • [38] Limb girdle muscular dystrophies
    Mensova, L.
    Baumgartner, D.
    Potockova, V.
    Mazanec, R.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (06) : 435 - 448
  • [39] Rhabdomyolysis featuring muscular dystrophies
    Lahoria, Rajat
    Milone, Margherita
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 361 : 29 - 33
  • [40] Glycosylation in congenital muscular dystrophies
    Endo, T
    Toda, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (12) : 1641 - 1647